XML 83 R12.htm IDEA: XBRL DOCUMENT

Inventories

12 Months Ended

Dec. 31, 2012

Note 5 — Inventories

Inventories consisted of the following (in thousands):


	December 31,
			2011
			Restated
	2012		(Note 2)
Raw materials	$	3,184	$	1,797
Work in progress		904		84
Finished goods		6,336		9,260
	$	10,424	$	11,141

As of December 31, 2012 and 2011, the Company had $2.3 million in inventory held at distributors related to products sold by its NovaMed subsidiary.

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details